Showing results (91-100 of 385) with videos related to
Sort By:
Pageof 39
Cellular and Molecular Neurobiology|June 5, 2002
6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's diseaseH Elkon, E Melamed, D OffenBrain Research Bulletin|February 1, 1987
Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretionS Feldman, N Conforti, E MelamedJournal of Neural Transmission. Supplementum|December 29, 2000
Apoptosis as a general cell death pathway in neurodegenerative diseasesD Offen, H Elkon, E MelamedCellular and Molecular Neurobiology|September 25, 2001
Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease?A Barzilai, E Melamed, A ShirvanNeurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 6, 2007
Primary postural instability: a cause of recurrent sudden falls in the elderlyR Djaldetti, M Lorberboym, E MelamedHandbook of Experimental Pharmacology|June 8, 2007
Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseasesI Kan, E Melamed, D OffenClinical Neuropharmacology|January 1, 1986
Delayed onset of responses to single doses of L-dopa in parkinsonian fluctuators on long-term L-dopa therapyE Melamed, V Bitton, O ZeligIsrael Journal of Medical Sciences|December 1, 1996
Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson's diseaseR Djaldetti, I Ziv, E MelamedNeurology|January 1, 1986
Episodic unresponsiveness to single doses of L-dopa in parkinsonian fluctuatorsE Melamed, V Bitton, O ZeligExperientia|November 15, 1976
Beta-adrenergic receptors in rat myocardium: direct detection by a new fluorescent beta-blockerE Melamed, M Lahav, D AtlasPageof 39